Further in vitro study on MM cell line with no mutation in β5 subunit revealed evidence that increased IGF-1 signalling through enhanced IGF-1 secretion and IGF-1R activation was also associated with resistance to bortezomib [102]. This evidence concerns the gene IGF1 and Miyoshi myopathy.